Current and historical gross, operating and net profit margin for Baxter (BAX) over the last 10 years. The current net profit margin for Baxter as of June 30, 2018 is 8.29%.
|Baxter Annual Profit Margin Summary
|Baxter Quarterly Profit Margin Summary
||Medical Products Manufacturing
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.